Chronic Kidney Disease
Study finds no evidence of causal effect between CKD, cannabis
According to data published in Kidney Medicine, there is no evidence that cannabis use causes chronic kidney disease, and researchers of the study suggest CKD should not be a limiting factor for cannabis use.
High body water mass associated with risk for sleep apnea
Individuals with high body water mass appeared to have an increased risk for sleep apnea, possibly mediated by pathologic edema, according to a study published in Annals of the American Thoracic Society.
Children with CKD more likely to be identified as hypertensive with 2017 guidelines
Based on both clinic and ambulatory blood pressure, children with chronic kidney disease are more likely to be grouped as hypertensive when using the American Academy of Pediatrics 2017 clinical practice guidelines vs. its 2004 guidelines.
Worsening diet can predict earlier death in adults with CKD
Declining diet quality could be a predictor of earlier death among adults with chronic kidney disease, according to a research letter published in American Journal of Kidney Diseases.
Amgen to acquire Horizon Therapeutics for $28.3 billion
Amgen Inc., which has established its mark in kidney care as the dominant supplier of anemia treatments, agreed to buy Ireland-based Horizon Therapeutics plc for $28.3 billion in a cash offer.
Increased serum bicarbonate correlates with reduced risk of kidney transplant loss, death
Increases in serum bicarbonate, even at a small level, correlated with reduced risk of graft loss, all-cause mortality, cardiovascular events and hospitalization, according to data published in Kidney Medicine.
‘Complex’ relationship between obesity, CKD requires early, aggressive treatment
Increased fat mass, particularly visceral adiposity, promotes kidney disease generation and progression through direct and indirect mechanisms, and pharmacologic treatment is necessary to avoid adverse outcomes, according to a speaker.
Persistent microscopic hematuria correlates with increased risk of CKD in men, women
Men and women with persistent microscopic hematuria are at an increased risk for the development of chronic kidney disease, according to data published in the American Journal of Kidney Diseases.
Dapagliflozin reduces hospitalization risk in adults with chronic kidney disease
The SGLT2 inhibitor dapagliflozin was associated with a reduced risk for hospitalization due to any cause in patients with chronic kidney disease with and without type 2 diabetes, according to a post hoc analysis of the DAPA-CKD trial.
Hospitalizations lower for patients with advanced CKD who choose conservative management
ORLANDO — Patients with advanced chronic kidney disease who choose conservative management have lower hospitalization rates vs. patients who choose dialysis, according to a study presented at ASN Kidney Week.